As of 2025-05-16, the Relative Valuation of Knight Therapeutics Inc (GUD.TO) is 0.40 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 5.87 CAD, the upside of Knight Therapeutics Inc based on Relative Valuation is -93.1%.
The range of the Relative Valuation is 0.25 - 1.58 CAD.
| Range | Selected | |
| Trailing P/E multiples | 5.7x - 32.6x | 7.1x |
| Forward P/E multiples | 4.3x - 17.0x | 5.4x |
| Fair Price | 0.25 - 1.58 | 0.40 |
| Upside | -95.8% - -73.2% | -93.1% |
| Date | P/E |
| 2025-05-14 | 132.69 |
| 2025-05-13 | 133.38 |
| 2025-05-12 | 134.53 |
| 2025-05-09 | 131.08 |
| 2025-05-08 | 130.40 |
| 2025-05-07 | 139.35 |
| 2025-05-06 | 139.81 |
| 2025-05-05 | 139.58 |
| 2025-05-02 | 141.65 |
| 2025-05-01 | 140.73 |
| 2025-04-30 | 139.58 |
| 2025-04-29 | 137.51 |
| 2025-04-28 | 135.91 |
| 2025-04-25 | 135.45 |
| 2025-04-24 | 133.84 |
| 2025-04-23 | 132.46 |
| 2025-04-22 | 131.31 |
| 2025-04-21 | 132.69 |
| 2025-04-17 | 130.63 |
| 2025-04-16 | 131.31 |
| 2025-04-15 | 131.77 |
| 2025-04-14 | 132.46 |
| 2025-04-11 | 128.33 |
| 2025-04-10 | 124.66 |
| 2025-04-09 | 130.17 |
| 2025-04-08 | 129.02 |
| 2025-04-07 | 130.63 |
| 2025-04-04 | 134.53 |
| 2025-04-03 | 140.04 |
| 2025-04-02 | 141.65 |
| 2025-04-01 | 141.65 |
| 2025-03-31 | 141.19 |
| 2025-03-28 | 139.81 |
| 2025-03-27 | 137.74 |
| 2025-03-26 | 138.66 |
| 2025-03-25 | 137.97 |
| 2025-03-24 | 137.05 |
| 2025-03-21 | 141.87 |
| 2025-03-20 | 143.94 |
| 2025-03-19 | 143.48 |
| 2025-03-18 | 142.10 |
| 2025-03-17 | 141.65 |
| 2025-03-14 | 137.51 |
| 2025-03-13 | 134.99 |
| 2025-03-12 | 140.04 |
| 2025-03-11 | 137.74 |
| 2025-03-10 | 125.12 |
| 2025-03-07 | 125.80 |
| 2025-03-06 | 127.41 |
| 2025-03-05 | 128.56 |